Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-24-012049
Filing Date
2024-03-29
Accepted
2024-03-29 17:28:51
Documents
53
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 1212729
2 ex4-4.htm EX-4.7 8674
3 ex31-1.htm EX-31.1 13706
4 ex31-2.htm EX-31.2 13735
5 ex32-1.htm EX-32.1 6478
6 ex32-2.htm EX-32.2 6874
7 ex97-1.htm EX-97.1 38308
8 form10-k_003.jpg GRAPHIC 11414
9 form10-k_001.jpg GRAPHIC 26956
10 form10-k_002.jpg GRAPHIC 22082
  Complete submission text file 0001493152-24-012049.txt   3587628

Data Files

Seq Description Document Type Size
11 XBRL SCHEMA FILE telo-20231231.xsd EX-101.SCH 20944
12 XBRL CALCULATION FILE telo-20231231_cal.xml EX-101.CAL 32870
13 XBRL DEFINITION FILE telo-20231231_def.xml EX-101.DEF 76603
14 XBRL LABEL FILE telo-20231231_lab.xml EX-101.LAB 181152
15 XBRL PRESENTATION FILE telo-20231231_pre.xml EX-101.PRE 149448
56 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 217998
Mailing Address 900 WEST PLATT STREET, SUITE 200 TAMPA FL 33606
Business Address 900 WEST PLATT STREET, SUITE 200 TAMPA FL 33606 (813) 864-2562
Telomir Pharmaceuticals, Inc. (Filer) CIK: 0001971532 (see all company filings)

EIN.: 872606031 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-41952 | Film No.: 24804907
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)